|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.6 EUR | +5.52% |
|
+16.35% | -8.93% |
| 28/06 | German Stocks Rise for Second Session | DJ |
| 28/06 | SCHOTT PHARMA : UBS remains Neutral | ZD |
SCHOTT Pharma AG & Co. KGaA reported earnings results for the half year ended March 31, 2024. For the half year, the company reported sales was EUR 466.45 million compared to EUR 448.73 million a year ago.
Net income was EUR 69.45 million compared to EUR 86.66 million a year ago. Basic earnings per share from continuing operations was EUR 0.46 compared to EUR 0.58 a year ago. Diluted earnings per share from continuing operations was EUR 0.46 compared to EUR 0.58 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.93% | 4.94B | |
| -5.60% | 181B | |
| -4.45% | 101B | |
| -4.15% | 67.54B | |
| -8.63% | 45.09B | |
| +9.70% | 44.37B | |
| +6.13% | 40.7B | |
| +15.22% | 29.85B | |
| +14.80% | 24.49B | |
| -6.46% | 23.99B |
SCHOTT PHARMA AG & CO. KGAA 
